Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;34(4):323-8.
doi: 10.1007/s00292-012-1613-9.

[Immunocytochemistry of p16(INK4a) and Ki-67 as adjunctive method for routine gynecological cytology of mild and moderate dysplasia]

[Article in German]
Affiliations

[Immunocytochemistry of p16(INK4a) and Ki-67 as adjunctive method for routine gynecological cytology of mild and moderate dysplasia]

[Article in German]
P Ziemke et al. Pathologe. 2013 Jul.

Abstract

Especially the cytological diagnoses of mild and moderate dysplasia are often followed by unnecessary stigmatization of patients and uncertainty in further clinical follow-up and therapy. Data from 222 patients including additional investigations by high-risk human papillomavirus (HPV) testing and combined immunocytochemistry for p16(INK4a) and Ki-67 were documented, including cytological and histological follow-up. Overall for cytology, high risk HPV testing and dual staining the following characteristics concerning the presence of cervical intraepithelial neoplasia (CIN) 2+ were calculated (in %): sensitivity 100, 95.8 and 92.4, specificity -, 23.3 and 72.8, positive predictive value 53.6, 59.1 and 79.7, negative predictive value -, 82.8 and 89.3, respectively.There was a statistically significant advantage for higher specificity and positive predictive value for dual staining, especially for cytological diagnosis of low grade dysplasia. An objective individual risk stratification of patients with cytology of mild or moderate dysplasia is not available but the uncertainty in the management of these patients will be clearly reduced.

PubMed Disclaimer

References

    1. Obstet Gynecol. 1986 May;67(5):665-9 - PubMed
    1. Acta Cytol. 2004 Nov-Dec;48(6):771-82 - PubMed
    1. Pathologe. 2011 Nov;32(6):451-60 - PubMed
    1. Geburtshilfe Frauenheilkd. 1978 Sep;38(9):726-34 - PubMed
    1. Acta Cytol. 2009 May-Jun;53(3):253-62 - PubMed

Publication types

MeSH terms

LinkOut - more resources